Company Performance Metrics
- Sigalit Carmel: Chief Executive Officer
Bioimmunate is a medical device company that offers a breakthrough precision blood filtering medical technology for select autoimmune diseases. Its platform technology has initial focus on the treatment of patients with multiple sclerosis or MS. Specific MS-related cells that migrate from the blood to the brain cause brain damage from MS. It has
developed biological filters anchored inside special particles that are able to recognize, capture, and remove these harmful cells from the patient’s blood before they reach the central nervous system. It seeks to improving the quality of life of patients with autoimmune diseases, seeking to provide safer, more cost-effective therapies without side effects. Its main research and development laboratory is in the BioGiv Center at the Hebrew University in Jerusalem.
